FREMONT, CA--(Marketwire - February 22, 2008) - Cardima, Inc. (OTCBB: CADM) announced the appointment of Dr. Sanjeev Saksena to its Scientific Advisory Board as an FDA Regulatory Consultant. Dr. Saksena is a trained Cardiologist and Cardiac Electrophysiologist with an international reputation; he has published extensively and lectured internationally. Dr. Saksena's role as Clinical Trial Study Chair will be to support the FDA approval process for Cardima's EP Ablation System for the treatment of Atrial Fibrillation ("AF").
